4//SEC Filing
Grant Sean 4
Accession 0001415889-25-004846
CIK 0001831828other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:08 PM ET
Size
8.2 KB
Accession
0001415889-25-004846
Insider Transaction Report
Form 4
Grant Sean
CHIEF FINANCIAL OFFICER
Transactions
- Award
Class A Common Stock
2025-02-18+26,900→ 93,237 total - Award
Stock Option (right to buy)
2025-02-18+53,800→ 53,800 totalExercise: $29.18Exp: 2035-02-17→ Class A Common Stock (53,800 underlying)
Holdings
- 5,000(indirect: By Trust)
Class A Common Stock
Footnotes (2)
- [F1]Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service through each vesting date.
- [F2]1/48 of the shares subject to the stock option will vest and become exercisable on March 18, 2025, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001872792
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:08 PM ET
- Size
- 8.2 KB